|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-4-9
|
|
pubmed:abstractText |
Although transcatheter arterial chemoembolization (TACE) is effective in hepatocellular carcinoma (HCC), it is not considered a curative procedure. Among the factors potentially interfering with its effectiveness is a hypothetical neoangiogenic reaction due to ischemia. In our study, we evaluated the changes in the levels of two angiogenic factors (vascular endothelial growth factor [VEGF] and basic fibroblast growth factor [b-FGF]) and one parameter of invasiveness (urokinase-type plasminogen activator [uPA]) in patients treated with TACE.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1572-0241
|
|
pubmed:author |
pubmed-author:BaldanAnnaA,
pubmed-author:BurraPatriziaP,
pubmed-author:CardinRomildaR,
pubmed-author:CilloUmbertoU,
pubmed-author:CristoforiChiaraC,
pubmed-author:FarinatiFabioF,
pubmed-author:GiacominAnnaA,
pubmed-author:GirardiLisaL,
pubmed-author:PivettaGiorgioG,
pubmed-author:RagazziRobertoR,
pubmed-author:SergioAdrianaA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
914-21
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:18177453-Aged,
pubmed-meshheading:18177453-Carcinoma, Hepatocellular,
pubmed-meshheading:18177453-Chemoembolization, Therapeutic,
pubmed-meshheading:18177453-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:18177453-Epirubicin,
pubmed-meshheading:18177453-Female,
pubmed-meshheading:18177453-Fibroblast Growth Factor 2,
pubmed-meshheading:18177453-Humans,
pubmed-meshheading:18177453-Infusions, Intra-Arterial,
pubmed-meshheading:18177453-Iodized Oil,
pubmed-meshheading:18177453-Liver Neoplasms,
pubmed-meshheading:18177453-Lymphatic Metastasis,
pubmed-meshheading:18177453-Male,
pubmed-meshheading:18177453-Middle Aged,
pubmed-meshheading:18177453-Neoplasm Invasiveness,
pubmed-meshheading:18177453-Neoplasm Staging,
pubmed-meshheading:18177453-Neovascularization, Pathologic,
pubmed-meshheading:18177453-Prognosis,
pubmed-meshheading:18177453-Proportional Hazards Models,
pubmed-meshheading:18177453-Statistics, Nonparametric,
pubmed-meshheading:18177453-Survival Rate,
pubmed-meshheading:18177453-Urokinase-Type Plasminogen Activator,
pubmed-meshheading:18177453-Vascular Endothelial Growth Factor A
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
|
|
pubmed:affiliation |
Istituto Oncologico Veneto, Padova, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
